A bacteriophage endolysin that eliminates intracellular streptococci

  1. Yang Shen
  2. Marilia Barros
  3. Tarek Vennemann
  4. D Travis Gallagher
  5. Yizhou Yin
  6. Sara B Linden
  7. Ryan D Heselpoth
  8. Dennis J Spencer
  9. David M Donovan
  10. John Moult
  11. Vincent A Fischetti
  12. Frank Heinrich
  13. Mathias Lösche
  14. Daniel C Nelson  Is a corresponding author
  1. University of Maryland, College Park, United States
  2. Carnegie Mellon University, United States
  3. The Rockefeller University, United States
  4. United States Department of Agriculture, United States

Abstract

PlyC, a bacteriophage-encoded endolysin, lyses Streptococcus pyogenes (Spy) on contact. Here, we demonstrate that PlyC is a potent agent for controlling intracellular Spy that often underlies refractory infections. We show that the PlyC holoenzyme, mediated by its PlyCB subunit, crosses epithelial cell membranes and clears intracellular Spy in a dose-dependent manner. Quantitative studies using model membranes establish that PlyCB interacts strongly with phosphatidylserine (PS) whereas its interaction with other lipids is weak, suggesting specificity for PS as its cellular receptor. Neutron reflection further substantiates that PlyC penetrates bilayers above a PS threshold concentration. Crystallography and docking studies identify key residues that mediate PlyCB-PS interactions, which are validated by site-directed mutagenesis. This is the first report that a native endolysin can translocate epithelial membranes, thus substantiating the potential of PlyC as an antimicrobial for Spy in the extra- and intracellular milieu and as a scaffold for engineering other functionalities.

Article and author information

Author details

  1. Yang Shen

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  2. Marilia Barros

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  3. Tarek Vennemann

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  4. D Travis Gallagher

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  5. Yizhou Yin

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  6. Sara B Linden

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  7. Ryan D Heselpoth

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  8. Dennis J Spencer

    Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, United States
    Competing interests
    No competing interests declared.
  9. David M Donovan

    Animal Biosciences and Biotechnology Lab, Agricultural Research Service, United States Department of Agriculture, Beltsville, United States
    Competing interests
    No competing interests declared.
  10. John Moult

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  11. Vincent A Fischetti

    Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, United States
    Competing interests
    Vincent A Fischetti, An inventor of U.S. patents(numbers 6,608,187, 7,582,729, and 7,838,255), which pertain to PlyC.
  12. Frank Heinrich

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  13. Mathias Lösche

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  14. Daniel C Nelson

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    For correspondence
    nelsond@umd.edu
    Competing interests
    Daniel C Nelson, An inventor of U.S. patents(numbers 6,608,187, 7,582,729, and 7,838,255), which pertain to PlyC.

Ethics

Human subjects: For primary epithelial cell cultures, the experimental protocol received Institutional Review Board approvals from both the Rockefeller University (VAF-0621-1207) and the Weill Cornell Medical College (nos. 0803009695 and 0806009857). Individual patient consent for the use of tissue in research applications was obtained prior to the surgical procedure.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 4,570
    views
  • 975
    downloads
  • 64
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yang Shen
  2. Marilia Barros
  3. Tarek Vennemann
  4. D Travis Gallagher
  5. Yizhou Yin
  6. Sara B Linden
  7. Ryan D Heselpoth
  8. Dennis J Spencer
  9. David M Donovan
  10. John Moult
  11. Vincent A Fischetti
  12. Frank Heinrich
  13. Mathias Lösche
  14. Daniel C Nelson
(2016)
A bacteriophage endolysin that eliminates intracellular streptococci
eLife 5:e13152.
https://doi.org/10.7554/eLife.13152

Share this article

https://doi.org/10.7554/eLife.13152

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Federico A Vignale, Andrea Hernandez Garcia ... Adrian G Turjanski
    Research Article

    Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.